Brenda Weigel Was Appointed As The VP of Clinical Research at St. Jude Children’s Research Hospital
Career Updates
Brenda Weigel was appointed as the VP of Clinical Research at St. Jude Children’s Research Hospital.
About the role
Brenda Weigel, MD, is the Director of Pediatric Hematology/Oncology at the University of Minnesota and a Professor at both the Masonic Cancer Center and the Department of Pediatrics. She holds the Lehman/Children’s Cancer Research Fund Endowed Chair in Pediatric Cancer and co-directs the Sarcoma Program at the Masonic Cancer Center. Dr. Weigel is also the medical director for the Masonic Cancer Center Clinical Trials Office. She earned her medical degree from McMaster University in Ontario and completed her pediatric residency at the University of Western Ontario. In 1996, she joined the University of Minnesota for a fellowship in Pediatric Hematology/Oncology and Bone Marrow Transplant, where she developed a rhabdomyosarcoma model in Bruce Blazar’s lab.
Responsibilities
- Advancing cancer therapies, particularly those leveraging the immune system
- Serving as Chair of the Developmental Therapeutics Committee
- Co-chairing the New High Risk Rhabdomyosarcoma Study
- Representing COG on the National Cancer Institute’s Investigational Drug Steering Committee
Requirements
Not specified
Qualifications
Not specified
Skills
Not specified
Benefits
Not specified
Pay
Not specified
Schedule
Not specified
St. Jude Children's Research Hospital
St. Jude Children’s Research Hospital officially welcomed Brenda Weigel as its new Vice President of Clinical Research.
OncoDaily
Stay Informed
Subscribe to OncoDaily Newsletter
Don't miss the latest news in oncology: stay up to date with daily picks from OncoDaily.
Subscribe